NFATC2 (nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2)
2012-07-01 Sietse J Luk  , Pancras CW Hogendoorn  , Karoly Szuhai   AffiliationDepartment of Molecular Cell Biology, Leiden University Medical Center, Einthovenweg 20, 2330 RC, Leiden, The Netherlands (SJL, KS); Department of Pathology, Leiden University Medical Center, Einthovenweg 20, 2330 RC, Leiden, The Netherlands (PCWH)
DNA/RNA

Description
Transcription
Proteins

Description
Another, highly conserved region of the NFAT family is the DNA binding domain that is structurally related to the DNA binding domain of the Rel-Family of transcription factors. This domain, called the REL homology region (RHR) is also responsible for binding partner proteins like the AP1 complex.
There are three alternative splice variants of the NFATC2 protein, all of which occur in the C-terminal domain of the protein (Macian, 2005).
Expression
Several kinases have been identified to rephosphorylate NFAT proteins at multiple sites, thereby controlling their nuclear shuttling. These kinases include glycogen-synthase kinase 3 (GSK3), casein kinase 1 (CK1), p38, and JUN N-terminal kinase (JNK). Some of them act as maintenance kinases, to keep the NFAT proteins in the cytosol in a fully phosphorylated state, preventing them from nuclear shuttling. Others act as export kinases; they rephosphorylate NFAT in the nucleus and thereby promote the nuclear export of NFAT, stopping the NFAT driven transcription after calcineurin activity declines.
Another regulatory mechanism has been discovered for NFAT proteins which uses a non-coding RNA (ncRNA). Functional analysis of ncRNAs found a Non-coding repressor of NFAT (NRON). When NRON was deactivated by small hairpin RNA (shRNA), a dramatic increase in NFAT activity was measured. NRON directly binds to 11 proteins, of which four are repressors of NFAT. NRON probably interacts with the nuclear shuttling of NFAT proteins which is demonstrated by an increase in nuclear localisation upon treatment with NRON shRNA (Rao et al., 1997; Willingham et al., 2005; Macian, 2005).
At this moment, 8 different microRNAs, which target 5 locations on the NFATC2 gene have been discovered (ensembl last viewed at 10-04-2012).
Localisation
Function
Implicated in


Both ETS family members, the EWS/FLI chimera and NFATC2 form complexes with AP-1. It has yet to be determined whether the EWSR1/NFATC2 chimera does this as well (Szuhai et al., 2009; Sankar et al., 2011).
Stat5, a member of the signal transducers and activators of transcription (stat) family of proteins, promotes tumor growth, but suppresses metastasis in breast cancer. NFATC2 has exactly the opposite effects; it inhibits tumor growth and promotes tumor metastasis. NFATC2 down regulates the Stat5 signaling pathway and vice versa. Also, the expression of the two genes is negatively correlated in a breast cancer progression tissue micro array (TMA). NFATC2 is expressed more in metastatic tissue than in normal tissue and primary tumor but Stat5 is the other way around (Zheng et al., 2011).
Experiments in mice have been performed to assess the influence of NFATC2 on metastasis formation and growth. Therefore NFATC2 null(-/-) mice were compared with NFATC2 normal(+/+) mice after intravenous injection of F16F10 melanoma cells. NFATC2-/- mice showed less and smaller metastases. Both the NFATC2 null(-/-) and wild type mice were treated with a wild type bone marrow transplantation to make sure differences were caused by the lack of NFATC2 in the lung parenchyma and not because of a dysfunction of the immune system (Werneck et al., 2011).
In hepatocellular carcinoma, colon carcinoma and breast cancer, NFATC2 plays an important role in regulating genes that affect tumoral phenotype such as cyclooxygenase-2 (COX-2). COX-2 is a key regulator in the expression of matrix metalloproteinase 1 and matrix metalloproteinase 2 and thereby of tumour invasion (Lara-Pezzi et al., 2002; Duque et al., 2005; Yiu et al., 2006).
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 15897878 | 2005 | Integrin alpha6beta4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells. | Chen M et al |
| 21192845 | 2011 | Expression and unique functions of four nuclear factor of activated T cells isoforms in non-small cell lung cancer. | Chen ZL et al |
| 15632146 | 2005 | Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2. | Duque J et al |
| 12975316 | 2003 | Transcriptional regulation by calcium, calcineurin, and NFAT. | Hogan PG et al |
| 12080349 | 2002 | The role of NFAT transcription factors in integrin-mediated carcinoma invasion. | Jauliac S et al |
| 12488433 | 2002 | The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. | Lara-Pezzi E et al |
| 15928679 | 2005 | NFAT proteins: key regulators of T-cell development and function. | Macian F et al |
| 9143705 | 1997 | Transcription factors of the NFAT family: regulation and function. | Rao A et al |
| 21872822 | 2011 | Promiscuous partnerships in Ewing's sarcoma. | Sankar S et al |
| 17175374 | 2007 | Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma. | Szuhai K et al |
| 19318479 | 2009 | The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology. | Szuhai K et al |
| 19783543 | 2009 | The TET family of proteins: functions and roles in disease. | Tan AY et al |
| 21225259 | 2011 | NFAT1 transcription factor is central in the regulation of tissue microenvironment for tumor metastasis. | Werneck MB et al |
| 16141075 | 2005 | A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. | Willingham AT et al |
| 17493814 | 2007 | NFAT signaling and the invention of vertebrates. | Wu H et al |
| 16505480 | 2006 | NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2. | Yiu GK et al |
| 21964595 | 2011 | Negative cross talk between NFAT1 and Stat5 signaling in breast cancer. | Zheng J et al |
Other Information
Locus ID:
NCBI: 4773
MIM: 600490
HGNC: 7776
Ensembl: ENSG00000101096
Variants:
dbSNP: 4773
ClinVar: 4773
TCGA: ENSG00000101096
COSMIC: NFATC2
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
PharmGKB
| Entity ID | Name | Type | Evidence | Association | PK | PD | PMIDs |
|---|---|---|---|---|---|---|---|
| PA33678 | PPP3CA | Gene | Pathway | associated | 23922006 | ||
| PA33679 | PPP3CB | Gene | Pathway | associated | 23922006 | ||
| PA33680 | PPP3CC | Gene | Pathway | associated | 23922006 | ||
| PA33681 | PPP3R1 | Gene | Pathway | associated | 23922006 | ||
| PA33682 | PPP3R2 | Gene | Pathway | associated | 23922006 | ||
| PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Disease | ClinicalAnnotation | associated | PD | 25987655 | |
| PA448492 | asparaginase | Chemical | ClinicalAnnotation | associated | PD | 25987655 |
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37933452 | 2024 | Genetic deficiency of the transcription factor NFAT1 confers protection against fibrogenic responses independent of immune influx. | 0 |
| 38254207 | 2024 | Report and literature review of four cases of EWSR1::NFATC2 round cell sarcoma. | 0 |
| 38448411 | 2024 | The RNA m(6)A reader IGF2BP3 regulates NFAT1/IRF1 axis-mediated anti-tumor activity in gastric cancer. | 1 |
| 38528665 | 2024 | The Dual Role of the NFATc2/galectin-9 Axis in Modulating Tumor-Initiating Cell Phenotypes and Immune Suppression in Lung Adenocarcinoma. | 1 |
| 37933452 | 2024 | Genetic deficiency of the transcription factor NFAT1 confers protection against fibrogenic responses independent of immune influx. | 0 |
| 38254207 | 2024 | Report and literature review of four cases of EWSR1::NFATC2 round cell sarcoma. | 0 |
| 38448411 | 2024 | The RNA m(6)A reader IGF2BP3 regulates NFAT1/IRF1 axis-mediated anti-tumor activity in gastric cancer. | 1 |
| 38528665 | 2024 | The Dual Role of the NFATc2/galectin-9 Axis in Modulating Tumor-Initiating Cell Phenotypes and Immune Suppression in Lung Adenocarcinoma. | 1 |
| 36779231 | 2023 | Linear ubiquitination improves NFAT1 protein stability and facilitates NFAT1 signalling in Kawasaki disease. | 0 |
| 36939112 | 2023 | No NFATC2 fusion in simple bone cyst of the jaw. | 0 |
| 37285922 | 2023 | Oncogenic Role of the NFATC2/NEDD4/FBP1 Axis in Cholangiocarcinoma. | 1 |
| 37904191 | 2023 | NFAT1 and NFκB regulates expression of the common γ-chain cytokine receptor in activated T cells. | 0 |
| 37909980 | 2023 | Over-expression of cFos by the Transcription Factors NFATc2 and Sp1 in Pancreatic Cancer Cells. | 0 |
| 38035702 | 2023 | Effect of NFATc2- and Sp1-mediated TNFalpha Regulation on the Proliferation and Migration Behavior of Pancreatic Cancer Cells. | 0 |
| 36779231 | 2023 | Linear ubiquitination improves NFAT1 protein stability and facilitates NFAT1 signalling in Kawasaki disease. | 0 |
Citation
Sietse J Luk ; Pancras CW Hogendoorn ; Karoly Szuhai
NFATC2 (nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2)
Atlas Genet Cytogenet Oncol Haematol. 2012-07-01
Online version: http://atlasgeneticsoncology.org/gene/44004/nfatc2-(nuclear-factor-of-activated-t-cells-cytoplasmic-calcineurin-dependent-2)
